Hematologic disorders associated with ischemic stroke
Department of Neurology
Anemia, Sickle Cell; Antibodies, Antiphospholipid; Anticoagulants; Antithrombin III Deficiency; Blood Platelet Disorders; Brain Ischemia; Cerebrovascular Disorders; Hematologic Diseases; Humans; Polycythemia Vera; Protein C Deficiency; Protein S Deficiency
Nervous System Diseases | Neurology
Hematological disorders underlie a small proportion of all ischemic strokes. The association of these coagulation abnormalities with ischemic stroke is not always clear. The etiology of stroke still remains uncertain in a large number of cases and proper screening for coagulation abnormalities and the discovery of new coagulation disorders will probably increase the rate of strokes attributable to these causes. Since large case-control studies with unselected and consecutive stroke patients from different ethnic origins have not yet been performed to determine the role of coagulation abnormalities in ischemic stroke, our knowledge is dependent on case reports and small series of mostly younger patients. Extensive hematologic evaluation of unselected stroke patients will likely yield little useful information and be too expensive. Every stroke patients needs a careful evaluation, and in selected cases, this should include coagulation parameters. Patients with unexplained strokes after a careful evaluation, previous thrombotic episodes, or a positive family history for thrombosis, are good candidates for further coagulation studies. As long as the hypercoagulable state persists, both arterial and venous thromboembolic recurrences can be expected. Many of these patients may benefit from anticoagulants. In patients with hereditary coagulation disorders, studies should be extended to close relatives. Since some coagulation tests are fairly expensive, provide only equivocal data, and are not widely available, we advise a step-by-step approach starting with the patient and family history.
Rights and Permissions
Citation: J Neurol Sci. 1996 Sep 1;140(1-2):1-11.